Chronic cold exposure, exercise, cyclic AMP, and PPARγ agonists are all examples of stimuli that can elicit the browning process (Wu et al., 2012; Ikeda et al., 2018), and scientists are actively pursuing other agents able to target this process to treat metabolic diseases. Here, PPARG is linked to metabolic disease.